TPG Group Holdings (SBS) Advisors’s Allogene Therapeutics ALLO Stock Holding History

TPG Group Holdings (SBS) Advisors’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$481M	Hold	18,716,306	–	–	4.77%	5
2021 Q2	$488M	Hold	18,716,306	–	–	3.48%	6
2021 Q1	$661M	Hold	18,716,306	–	–	7.71%	4
2020 Q4	$472M	Hold	18,716,306	–	–	5.23%	5
2020 Q3	$706M	Sell	18,716,306 -1,000,000	-5%	-$37.7M	12.65%	1
2020 Q2	$844M	Sell	19,716,306 -1,500,000	-7%	-$54.2M	14.91%	1
2020 Q1	$412M	Hold	21,216,306	–	–	9.5%	3
2019 Q4	$551M	Hold	21,216,306	–	–	8.13%	5
2019 Q3	$578M	Hold	21,216,306	–	–	8.52%	4
2019 Q2	$570M	Sell	21,216,306 -1,918,755	-8%	-$53.5M	8.58%	3
2019 Q1	$669M	Hold	23,135,061	–	–	13.15%	2
2018 Q4	$623M	Buy	+23,135,061	New	+$615M	10.06%	3

Other funds holding ALLO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors's ALLO Position: Q3 2021 in Review

TPG Group Holdings (SBS) Advisors held its Allogene Therapeutics (ALLO) position steady in Q3 2021 at 18,716,306 shares worth $481M. The position accounts for 4.77% of the portfolio, ranked #5.

TPG Group Holdings (SBS) Advisors first reported a position in ALLO in Q4 2018 and has held it in 12 quarters since. The position peaked at $844M in Q2 2020. 169 funds tracked by Wall St. Rank hold ALLO as of Q3 2021.

TPG Group Holdings (SBS) Advisors held 18,716,306 shares of Allogene Therapeutics worth $481M as of Q3 2021.
TPG Group Holdings (SBS) Advisors left its Allogene Therapeutics share count unchanged in Q3 2021.
Allogene Therapeutics made up 4.77% of TPG Group Holdings (SBS) Advisors's portfolio in Q3 2021, its #5 holding.
TPG Group Holdings (SBS) Advisors first reported a position in Allogene Therapeutics in Q4 2018 and has held it in 12 quarters since.
TPG Group Holdings (SBS) Advisors's Allogene Therapeutics position peaked at $844M in Q2 2020.
169 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2021.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.